Literature DB >> 24965015

Safety of transvenous lead extraction according to centre volume: a systematic review and meta-analysis.

Antonio Di Monaco1, Gemma Pelargonio1, Maria Lucia Narducci2, Lamberto Manzoli3, Stefania Boccia4, Maria Elena Flacco3, Lorenzo Capasso3, Lucy Barone1, Francesco Perna1, Gianluigi Bencardino1, Teresa Rio1, Milena Leo1, Luigi Di Biase5, Pasquale Santangeli6, Andrea Natale7, Antonio Giuseppe Rebuzzi1, Filippo Crea1.   

Abstract

BACKGROUND: Transvenous lead extraction (TLE) is a complex invasive procedure and the experience of the operator and the team is a major determinant of procedural outcomes. AIM: Because of very limited data available on minimum procedural volumes to enable training and ongoing competency for TLEs, we performed a meta-analysis aimed at assessing the outcomes of TLE in the centres with low, medium, and high volume of procedures.
METHODS: Of the 280 papers initially retrieved until February 2013, 66 observational studies met inclusion criteria and were included in at least one stratified meta-analysis: 17 were prospective studies; 47 had a retrospective design; and 2 were defined 'experience studies'. We included only articles published after the introduction of laser technique (year 1999). We divided the studies in low, medium, and high volume centres utilizing either the European Heart Rhythm Association (EHRA) or Lexicon classification criteria.
RESULTS: When meta-analyses were carried out separately for the studies with larger and smaller sample sizes, either using EHRA or Lexicon classification criteria, no clear differences emerged in the combined rate of major complications or intraoperative deaths. In contrast, both minor complications and mortality at 30 days decreased as centre volume increased.
CONCLUSIONS: In our meta-analysis of observational studies, patients who have been treated in higher volume centres have a lower probability of minor complications and death at 30 days regardless of the infection rate, length of lead duration, type of device, and type of extraction. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiac device infection; Cardiac device malfunction; Cardiac endocarditis; Centre volume; Transvenous lead extraction

Mesh:

Year:  2014        PMID: 24965015     DOI: 10.1093/europace/euu137

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  17 in total

1.  Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data Registry.

Authors:  Emily P Zeitler; Yongfei Wang; Kumar Dharmarajan; Kevin J Anstrom; Eric D Peterson; James P Daubert; Jeptha P Curtis; Sana M Al-Khatib
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-07

2.  The role of cardiac surgery in transvenous lead extraction. A high-volume center experience with 3207 procedures.

Authors:  Łukasz Tułecki; Marek Czajkowski; Sylwia Targońska; Konrad Tomków; Dorota Nowosielecka; Wojciech Jacheć; Anna Polewczyk; Andrzej Kutarski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2022-10-08

Review 3.  State-of-the-art narrative review: multimodality imaging in electrophysiology and cardiac device therapies.

Authors:  Balint Laczay; Divyang Patel; Richard Grimm; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

Review 4.  Prevention, Diagnosis, and Treatment of Cardiac Implantable Electronic Device Infections.

Authors:  Steven Leung; Stephan Danik
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

5.  Experience of cardiac implantable electronic device lead removal from a South African tertiary referral centre.

Authors:  Philasande Mkoko; Nicholus Xolani Mdakane; Glenda Govender; Jacques Scherman; Ashley Chin
Journal:  Cardiovasc J Afr       Date:  2021-04-19       Impact factor: 1.167

6.  Transvenous lead extraction outcomes using a novel hand-powered bidirectional rotational sheath as a first-line extraction tool in a low-volume centre.

Authors:  Jus Ksela; Jan Prevolnik; Mark Racman
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-08

7.  Effectiveness and Safety of Transvenous Removal of Cardiac Pacing and Implantable Cardioverter-defibrillator Leads in the Real Clinical Scenario.

Authors:  Roberto Costa; Katia Regina da Silva; Elizabeth Sartori Crevelari; Wagner Tadeu Jurevicius Nascimento; Marcia Mitie Nagumo; Martino Martinelli Filho; Fabio Biscegli Jatene
Journal:  Arq Bras Cardiol       Date:  2020-12       Impact factor: 2.000

8.  Persistent fever after pacemaker lead extraction.

Authors:  Maria Carmo Pereira Nunes; Túlio Pinho Navarro; Mariana de Braga Lima Carvalho; Nicole de Paula Aarão Faleiro Maia; Ricardo Jayme Procópio; Teresa Cristina Abreu Ferrari
Journal:  Indian Pacing Electrophysiol J       Date:  2016-08-20

9.  Lead Extraction of Cardiac Rhythm Devices: A Report of a Single-Center Experience.

Authors:  Ana Isabel Azevedo; João Primo; Helena Gonçalves; Marco Oliveira; Luís Adão; Elisabeth Santos; José Ribeiro; Marlene Fonseca; Adelaide V Dias; Luís Vouga; Vasco Gama Ribeiro
Journal:  Front Cardiovasc Med       Date:  2017-04-13

10.  Percutaneous Lead Extraction in Infection of Cardiac Implantable Electronic Devices: a Systematic Review.

Authors:  Antônio da Silva Menezes Júnior; Thaís Rodrigues Magalhães; Alana de Oliveira Alarcão Morais
Journal:  Braz J Cardiovasc Surg       Date:  2018 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.